Skip to main content
. 2021 Jan 2;70(6):1705–1719. doi: 10.1007/s00262-020-02817-z

Fig. 4.

Fig. 4

Validating the 17-immune-related gene signature in the test set. a Kaplan–Meier curves of overall survival of LUAD patients in high- and low-risk score groups. b Time-dependent receiver operating characteristic curves. c The distribution of risk scores. d The relationship between risk scores and survival times. e The expression patterns of 17 immune-related genes in high- and low-risk score groups